Dupilumab, an inhibitor of interleukin (IL)‐4/13 activity, is a biological agent approved for the treatment of moderate‐to‐severe atopic dermatitis (AD)...
Leggi tuttoIs exposure to topical calcineurin inhibitors among adult patients with atopic dermatitis associated with increased keratinocyte carcinoma risk?...
Leggi tuttoPatients with an impaired immune system have higher risk for melanoma, the most dangerous type of skin cancer, and a worse prognosis....
Leggi tuttoPsoriasis is a common inflammatory skin disease that can be associated with various pathological conditions among which arthritis is a frequent comorbidity....
Leggi tuttoAtypical network encompasses several patterns....
Leggi tuttoIdentifying Challenges and Practical Considerations for Successful Application...
Leggi tuttoA prospective observational study...
Leggi tuttoThe review is based on a search of peer-reviewed publications found using PubMed search tools and including the keywords identified above. In addition, the reference lists from other key articles were used to obtain other pertinent art...
Leggi tuttoadverse drug reaction, cancer, immune therapy, photoallergic, photosensitivity, phototoxic, reaction...
Leggi tuttoLyme disease is a tick-borne illness, which is typically caused by Borrelia Burgdoferi...
Leggi tuttoAtopic dermatitis (AD) is an inflammatory disease with a chronic-relapsing course that is intensely itchy....
Leggi tuttoAdvances in diagnostic techniques...
Leggi tuttoPemphigus encompasses a group of life‐threatening autoimmune bullous diseases characterized by blisters and erosions of the mucous membranes and skin....
Leggi tuttoVitiligo is a chronic autoimmune disease resulting in skin depigmentation and reduced quality of life....
Leggi tuttoIs the risk of severe cardiovascular events increased after the initiation of treatment with the anti–interleukin 12/23p40 (IL-12/23p40) monoclonal antibody ustekinumab?...
Leggi tuttopharmacokinetics, safety and efficacy...
Leggi tuttoResults from the PROCLIPI international Study...
Leggi tuttoa valid alternative to clindamycin in the panorama of antibiotic resistance...
Leggi tuttoPrimary cutaneous B-cell lymphomas (PCBCLs) comprise a group of extranodal B-cell non-Hodgkin lymphomas B-cell derived, which primarily involve the skin without evidence of extracutaneous disease at the time of diagnosis....
Leggi tuttoRisultati da 321 a 340 di 709